Drug intelligence / Profile preview

sodium chloride 0.9%

Development stage
Approved
Lead developer
Baxter
Modality
Small Molecules
Administration
Intravenous, Irrigation, Topical, Intramuscular, Subcutaneous
01

Overview

Sodium chloride 0.9%, commonly known as normal saline, is a sterile, nonpyrogenic, isotonic crystalloid solution containing 9 mg of sodium chloride per mL. It provides 154 mEq/L of sodium and 154 mEq/L of chloride ions, with an osmolarity of approximately 308 mOsmol/L, which is nearly isotonic with human plasma. As a fundamental parenteral fluid and electrolyte replenisher, it is used to treat extracellular fluid replacement, manage metabolic alkalosis in the presence of fluid loss, and serve as a vehicle for the dilution and administration of compatible prescription drugs. It is also utilized in specialized procedures such as apheresis kit priming and maintaining isovolemia. While ubiquitous in clinical settings, recent research in critical care has compared its efficacy and safety profile—specifically regarding the risk of acute kidney injury and hyperchloremic acidosis—against balanced crystalloids like Lactated Ringer's solution.

Brand names
0.9% Sodium Chloride Injection USP
Other names
normal salineisotonic salinephysiological salineNaCl 0.9%sodium chloride
02

Targets

SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on sodium chloride 0.9%.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium chloride 0.9%.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call